Changmao Biochemical Refinances RMB 93 Million Project Loan With 10-Year Bank LoanPUBT·Nov 9, 2026 at 08:35 AM009540.00%
Changmao Biochemical FY26 H1 net loss narrows to RMB 5.09 million; revenue rises 6.3% to RMB 289.55 millionPUBT·Sep 1, 2026 at 09:00 AM009540.00%
Changmao Biochemical FY26 H1 net loss narrows 80.88% to RMB 4.93 million; revenue rises 6.34% to RMB 289.55 millionPUBT·Aug 18, 2026 at 09:25 AM009540.00%
Changmao Biochemical expects H1 net loss narrows to RMB 4 million-RMB 6 millionPUBT·Aug 3, 2026 at 08:32 AM009540.00%
Changmao Biochemical schedules board meeting to review interim resultsPUBT·Aug 3, 2026 at 04:01 AM009540.00%
Changmao Biochemical Posts Another Annual Loss and Scraps Final Dividend for 2025Tip Ranks·Mar 30, 2026 at 04:22 PM009540.00%
CHANGMAO BIO announced its interim results, with a loss attributable to shareholders of 25.79 million yuan, an increase of 37.28% year-on-yearZhitong·Aug 18, 2025 at 10:09 AM009540.00%
CHANGMAO BIO issues a profit warning, expecting a mid-term net loss of approximately 24 million to 27 million yuanZhitong·Aug 1, 2025 at 08:42 AM009540.00%
"Profit Warning" CHANGMAO BIO is expected to have a mid-term loss expanded to approximately RMB 24 million to 27 millionAASTOCKS·Aug 1, 2025 at 08:33 AM009540.00%
CHANGMAO BIO's subsidiary signs a sale-leaseback contract for the machinery and equipment of the phthalic anhydride production lineZhitong·Jun 30, 2025 at 01:17 PM009540.00%
CHANGMAO BIO: Rui Xiaoqian will be appointed as Executive DirectorZhitong·Apr 23, 2025 at 04:09 AM009540.00%